TP53 germline testing and hereditary cancer: how somatic events and clinical criteria affect variant detection rate

Abstract Background Germline heterozygous pathogenic variants (PVs) in TP53 cause Li-Fraumeni syndrome (LFS), a condition associated with increased risk of multiple tumor types. As the associated cancer risks were refined over time, clinical criteria also evolved to optimize diagnostic yield. The im...

Full description

Saved in:
Bibliographic Details
Main Authors: Paula Rofes, Carmen Castillo-Manzano, Mireia Menéndez, Álex Teulé, Sílvia Iglesias, Elisabet Munté, Mireia Ramos-Muntada, Carolina Gómez, Eva Tornero, Esther Darder, Eva Montes, Laura Valle, Gabriel Capellá, Marta Pineda, Joan Brunet, Lidia Feliubadaló, Jesús del Valle, Conxi Lázaro
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Genome Medicine
Subjects:
Online Access:https://doi.org/10.1186/s13073-025-01429-5
Tags: Add Tag
No Tags, Be the first to tag this record!